TY - JOUR
T1 - Comparison of erythroid progenitor cell growth in vitro in polycythemia vera and chronic myelogenous leukemia
T2 - Only polycythemia vera has endogenous colonies
AU - Weinberg, Rona S.
AU - Worsley, Alison
AU - Gilbert, Harriet S.
AU - Cuttner, Janet
AU - Berk, Paul D.
AU - Alter, Blanche P.
PY - 1989
Y1 - 1989
N2 - The ability of erythroid cultures to distinguish among myeloproliferative disorders was examined. We studied 14 patients with polycythemia vera (PV), 11 with chronic myelogenous leukemia (CML), four with non-PV erythrocytosis, two with agnogenic myeloid metaplasia, as well as three normal fetuses and >25 normal adults. Endogenous, i.e. grew without added erythropoietin, bone marrow CFU-E-derived colonies were observed in all but one PV patient. However, endogenous blood BFU-E-derived bursts were observed in only eight of 14 PV patients. Endogenous erythroid colonies were not seen in cultures from any normal adults or fetuses, or patients with CML, erythrocytosis, or myeloid metaplasia. In PV, relative HbF synthesis was always greater in cultures without erythropoietin, while in cultures from all other patients relative HbF synthesis was similar to that observed in cultures from normal individuals. We conclude that PV and CML are distinguishable in culture since CML patients do not have endogenous growth. Most important, endogenous bone marrow CFU-E-derived colonies are the only consistently unique observation in patients with PV, and endogenous CFU-E- and BFU-E-derived colonies and bursts are not uniformly observed in PV blood cultures. In-vitro studies of erythropoiesis to confirm the diagnosis of PV, therefore, require marrow when endogenous colonies and bursts are absent from blood cultures.
AB - The ability of erythroid cultures to distinguish among myeloproliferative disorders was examined. We studied 14 patients with polycythemia vera (PV), 11 with chronic myelogenous leukemia (CML), four with non-PV erythrocytosis, two with agnogenic myeloid metaplasia, as well as three normal fetuses and >25 normal adults. Endogenous, i.e. grew without added erythropoietin, bone marrow CFU-E-derived colonies were observed in all but one PV patient. However, endogenous blood BFU-E-derived bursts were observed in only eight of 14 PV patients. Endogenous erythroid colonies were not seen in cultures from any normal adults or fetuses, or patients with CML, erythrocytosis, or myeloid metaplasia. In PV, relative HbF synthesis was always greater in cultures without erythropoietin, while in cultures from all other patients relative HbF synthesis was similar to that observed in cultures from normal individuals. We conclude that PV and CML are distinguishable in culture since CML patients do not have endogenous growth. Most important, endogenous bone marrow CFU-E-derived colonies are the only consistently unique observation in patients with PV, and endogenous CFU-E- and BFU-E-derived colonies and bursts are not uniformly observed in PV blood cultures. In-vitro studies of erythropoiesis to confirm the diagnosis of PV, therefore, require marrow when endogenous colonies and bursts are absent from blood cultures.
KW - chronic myelogenous leukemia
KW - endogenous colonies
KW - Erythroid colonies
KW - polycythemia vera
UR - http://www.scopus.com/inward/record.url?scp=0024580388&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024580388&partnerID=8YFLogxK
U2 - 10.1016/0145-2126(89)90070-2
DO - 10.1016/0145-2126(89)90070-2
M3 - Article
C2 - 2716348
AN - SCOPUS:0024580388
SN - 0145-2126
VL - 13
SP - 331
EP - 338
JO - Leukemia Research
JF - Leukemia Research
IS - 4
ER -